How should bleeding from a gastrostomy tube site be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of G-Tube Site Bleeding

Bleeding from a gastrostomy tube site should be managed by first identifying the cause—most commonly peptic ulcer disease, traumatic erosion from the internal bolster, or ulceration beneath the bumper—and immediately relieving excessive tension between the internal and external bolsters, which is the primary preventable cause. 1

Immediate Assessment and Intervention

When confronted with G-tube site bleeding, your first action is to loosen the external bolster to eliminate pressure-induced trauma. The external fixation plate should allow approximately 1 cm of free tube movement and maintain only loose contact with the skin—just enough to oppose the gastric and abdominal wall without creating tension 1. Excessive tightening is a common pitfall that causes pressure necrosis and gastric ulceration 2.

Identify the Bleeding Source

G-tube bleeding occurs in 0.3%–1.2% of cases and typically arises from three mechanisms 1:

  • Peptic ulcer disease (underlying gastric pathology)
  • Traumatic erosion of the gastric wall opposite the internal bolster
  • Ulceration beneath the internal bolster from excessive pressure

The protruding tip of balloon-type gastrostomy tubes can cause traumatic injury to gastric mucosa, leading to ulceration and hemorrhage 3.

Diagnostic Approach

Perform endoscopic evaluation to examine the mucosa under the internal bolster 1. This allows direct visualization of:

  • Ulceration at the bumper site
  • Gastric wall erosion opposite the bolster
  • Active bleeding sources requiring intervention

During endoscopy, assess whether the internal bolster is causing direct mucosal injury. In some cases, the balloon or dome-shaped internal bolster (typically 1.5-2.0 cm in height) creates focal pressure points 3.

Management Algorithm

For Minor Bleeding:

  1. Relieve all tension on the tube immediately
  2. Ensure 1 cm of free tube movement at the external bolster
  3. Avoid lateral traction on the tube
  4. Monitor for resolution

For Persistent or Severe Bleeding:

  1. Endoscopic evaluation to identify the exact source
  2. Consider tube replacement with a low-profile device (internal bumper only 0.3 mm in height) if traumatic ulceration is confirmed 3
  3. Tube removal and replacement at a different location may be necessary for refractory cases
  4. In rare cases with severe hemorrhage, tube removal may be required to achieve hemostasis 4

Prevention is Critical

The key to avoiding this complication lies in proper initial placement and ongoing care:

  • Never overtighten the external bolster—this is the most common preventable cause 1
  • Allow approximately 1 cm of play between skin and external bolster 1
  • Push the tube 2-3 cm ventrally during dressing changes, then carefully pull back to resistance to prevent adhesions and buried bumper syndrome 5
  • Use Y-compresses to cushion movements and avoid moist cavities 5

Important Caveats

Bleeding risk is not significantly increased by antiplatelet therapy. Recent evidence shows no significant difference in bleeding rates between dual antiplatelet therapy (DAPT), single antiplatelet agents, or no antiplatelet therapy during G-tube placement 6. The 2011 SIR guidelines recommend not withholding aspirin for G-tube procedures, though clopidogrel should be held for 5 days 1.

Severe bleeding requiring transfusion is rare but can occur, particularly in immunocompromised patients 4, 7. GI bleeding occurs in approximately 4.1% of cases within 30 days of insertion, with higher rates in immunocompromised patients and those with non-neurological indications 7.

If bleeding is associated with hemodynamic instability or signs of peritonitis, surgical consultation is mandatory 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.